CHURNA YIELD-BASED COMPARISON: IMPACT OF RAW DRUG VARIABILITY ON AYURVEDIC PHARMACEUTICAL STANDARDISATION

In Ayurveda, Churna (medicinal powders) are one of the most basic ways to give medicine, and they are still widely used in both traditional medicine and modern pharmacy practice. The output from raw drug materials has a big impact on the quality, effectiveness, and cost-effectiveness of Churna formulas. There is a lot of variation in Churna yield because of changes in the natural qualities of the drugs and outside factors like where they come from, the weather, when they are harvested, and how they are stored. Variability like this makes it hard to be consistent and standardised from batch to batch when making Ayurvedic medicines. This piece takes a critical look at the things that affect Churna yield, talks about what those things mean for pharmaceuticals, and stresses how important it is to combine yield-based assessment with well-known quality control standards. A lot of attention is paid to how the quality of the raw drug, handling losses, and regulatory standards affect the consistency and treatment effectiveness of Churna formulations.